Boehringer Ingelheim's net income in the first half of 2017 was 9.2 billion euros, and its diabetes business surged 59%

"BAHEAL Manufacturing" is making renewed efforts, and BAHEAL Pharmaceutical's Neshu ® Duloxetine Hydrochloride Enteric-coated Capsules is selected from the country.

SFDA: Starting from March 1, the provincial bureau will stop accepting applications for review and approval of drug technology transfer registration

Paiger became famous in the World War I and relay Pfizer's research and development of Class 1.1 new drugs for diabetes

In-depth report from central media 丨 Fu Gang: Exploring new momentum during the downturn of the pharmaceutical industry